Kinomica

Macclesfield, United Kingdom · Founded 2016 · Privately Held (backing)

Developer of a phosphoproteomic diagnostic platform designed to enhance tailored treatment decisions involving anticancer drug therapies. Kinomica is based in Macclesfield, United Kingdom and was founded in 2016. Its last known valuation is $16.6 million. It has raised $13.1 million.

Last price · $/share
—
Implied valuation
$16.6M
Total raised
$13.1M
Last round
—
What is Kinomica worth?
$16.6Mlast known valuation
Free account
More of Kinomica with a free account
  • ·The complete investor list: 11 names
  • ·Watch Kinomica: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kinomica funding history

No rounds on record

No funding rounds for Kinomica are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Kinomica valuation

Kinomica's last known valuation is $16.6 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How Kinomica's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Kinomica, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Kinomica

What is Kinomica worth?
Kinomica's last known valuation is $16.6M.
How much has Kinomica raised?
Kinomica has raised $13.1M in total funding across its recorded rounds.